F L McCabe

1.1k total citations
14 papers, 928 citations indexed

About

F L McCabe is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, F L McCabe has authored 14 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in F L McCabe's work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (3 papers) and Synthesis and Biological Evaluation (3 papers). F L McCabe is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (3 papers) and Synthesis and Biological Evaluation (3 papers). F L McCabe collaborates with scholars based in United States, United Kingdom and Canada. F L McCabe's co-authors include Michael R. Mattern, G A Hofmann, K. B. Tan, Richard K. Johnson, Randall K. Johnson, F H Drake, Wai-Kwong Eng, Richard Woessner, Robert Hertzberg and R K Johnson and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

F L McCabe

14 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F L McCabe United States	9	819	558	188	119	77	14	928
Yasuyoshi Kawato Japan	9	830 1.0×	647 1.2×	149 0.8×	129 1.1×	60 0.8×	11	1.1k
G A Hofmann United States	7	600 0.7×	336 0.6×	147 0.8×	78 0.7×	60 0.8×	10	657
S Kirschenbaum United States	7	576 0.7×	342 0.6×	141 0.8×	104 0.9×	25 0.3×	9	728
Janice Mayes United States	10	496 0.6×	301 0.5×	82 0.4×	77 0.6×	52 0.7×	17	549
Hellmuth R. Hinz United States	10	506 0.6×	324 0.6×	76 0.4×	42 0.4×	45 0.6×	13	566
Abdul M. Deffie Canada	9	539 0.7×	491 0.9×	50 0.3×	57 0.5×	22 0.3×	10	726
Yuan‐Chin Tsai United States	7	458 0.6×	351 0.6×	67 0.4×	105 0.9×	18 0.2×	12	833
JHM Schellens Netherlands	12	412 0.5×	448 0.8×	45 0.2×	25 0.2×	29 0.4×	16	626
D Abigerges France	8	607 0.7×	669 1.2×	37 0.2×	31 0.3×	40 0.5×	12	827
N Saijo Japan	12	302 0.4×	277 0.5×	43 0.2×	53 0.4×	12 0.2×	25	602

Countries citing papers authored by F L McCabe

Since Specialization

Citations

This map shows the geographic impact of F L McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F L McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F L McCabe more than expected).

Fields of papers citing papers by F L McCabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F L McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F L McCabe. The network helps show where F L McCabe may publish in the future.

Co-authorship network of co-authors of F L McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of F L McCabe. A scholar is included among the top collaborators of F L McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F L McCabe. F L McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Campion, Liam, Laura Johns, F L McCabe, et al.. (2009). Neutralizing CCL2 Inhibits Breast Tumor Growth Via Impact on the Tumor/Stroma Microenvironment.. Cancer Research. 69(24_Supplement). 6095–6095. 1 indexed citations

Vater, Carol A., Carol D. Manning, A. Harvey Millar, et al.. (2008). 529 POSTER Anti-tumor efficacy of the integrin-targeted immunoconjugate IMGN388 in preclinical models. European Journal of Cancer Supplements. 6(12). 167–168. 3 indexed citations

Mattern, Michael R., et al.. (1993). In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.. PubMed. 5(12). 467–74. 76 indexed citations

McCabe, F L, et al.. (1993). Synthesis of flavone-8-carboxylic acid analogues as potential antitumor agents. European Journal of Medicinal Chemistry. 28(5). 407–414. 9 indexed citations

Woessner, Richard, Wai-Kwong Eng, G A Hofmann, et al.. (1992). Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.. PubMed. 4(11-12). 481–8. 63 indexed citations

Grochow, L B, Eric K. Rowinsky, Randall S. Johnson, et al.. (1992). Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.. Drug Metabolism and Disposition. 20(5). 706–713. 111 indexed citations

Hoke, Glenn D., F L McCabe, Leo F. Faucette, et al.. (1991). In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane.. Molecular Pharmacology. 39(1). 90–97. 18 indexed citations

Kingsbury, William D., Jeffrey C. Boehm, Dalia R. Jakas, et al.. (1991). ChemInform Abstract: Synthesis of Water‐Soluble (Aminoalkyl)camptothecin Analogues: Inhibition of Topoisomerase I and Antitumor Activity.. ChemInform. 22(22). 1 indexed citations

Mattern, Michael R., G A Hofmann, F L McCabe, & Randall K. Johnson. (1991). Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).. PubMed. 51(21). 5813–6. 135 indexed citations

10.

Eng, Wai-Kwong, F L McCabe, K. B. Tan, et al.. (1990). Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.. Molecular Pharmacology. 38(4). 471–480. 106 indexed citations

11.

Tan, K. B., et al.. (1989). Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase Inhibitors. JNCI Journal of the National Cancer Institute. 81(22). 1732–1735. 142 indexed citations

12.

Stadel, Jeffrey M., R K Johnson, Christopher K. Mirabelli, et al.. (1988). Tumorigenicity of the cyc- variant of the S49 murine lymphoma deficient in the Gs-alpha subunit of adenylate cyclase.. PubMed. 48(3). 641–4. 2 indexed citations

13.

Mirabelli, Christopher K., et al.. (1988). A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.. PubMed. 48(19). 5447–54. 5 indexed citations

14.

Drake, F H, et al.. (1987). Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.. Journal of Biological Chemistry. 262(34). 16739–16747. 256 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact